Vice President of Operations
Ms. Sullivan has decades of experience in intellectual property, contracts and business operations in biotechnology, including her current role as Vice President of Operations, Intellectual Property & Contracts at Himalaya Therapeutics and Vice President of Intellectual Property & Contracts at BioAtla, and her previous roles serving as Vice President at Capia IP LLC, and the Head of Intellectual Property at Diversa Corporation (now BASF), among other responsibilities, during her 10 year tenure there. Ms. Sullivan is part of a team that has raised over USD $500MM (HKD 4 billion) in biotechnology. As the head of Diversa’s intellectual property group she managed a robust patent portfolio including responsibility for IP strategy, US and foreign prosecution, interferences and oppositions, litigation strategy, landscape analyses, freedom to operate analyses, diligence proceedings, licensing, technology transfer and biodiversity access. Before joining Diversa Corporation, Ms. Sullivan served in multiple roles for six years at Stratagene Cloning Systems, a molecular biology company based in La Jolla, California, including responsibility for patent prosecution, litigation, contracts, and management of an antibody licensing program with over 2,000 licensees. Ms. Sullivan attended the University of California, San Diego and has a background in Molecular Biology.